ARTICLE |
Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy
Affiliations of authors: Brain Korea 21 Project for Medical Sciences, Institute for Cancer Research, Yonsei Cancer Center (JHK, YSL, JHH, ARY, COY) and Department of Pathology (HK), Yonsei University College of Medicine, Seoul, Korea
Correspondence to: Chae-Ok Yun, PhD, Yonsei Cancer Center, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemun-Gu, Seoul, Korea (e-mail: chaeok{at}yumc.yonsei.ac.kr).
Background: The use of oncolytic adenoviruses as cancer gene therapy is limited by their uneven penetration and distribution in tumors. We investigated whether the expression of the cell matrix–degradative protein relaxin by adenovirus could improve adenovirus distribution and penetration in tumors. Methods: We generated relaxin-expressing, replication-incompetent (dl-lacZ-RLX) and -competent (Ad-
E1B-RLX) adenoviruses by inserting a relaxin gene into the E3 adenoviral region. Controls were parental adenoviruses (dl-lacZ and Ad-E1B) and phosphate-buffered saline (PBS) (vehicle). Replication-incompetent viruses, which do not lyse cells, were used to assess transduction efficiency. Viral spread in tumor spheroids, made by dissecting tumor tissue into homogeneous fragments, was assessed by reporter gene (i.e., lacZ) expression. Tumor growth inhibition was assessed by injecting adenoviruses into xenograft tumors in athymic mice (n = 8 or 9). Overall survival was assessed by the Kaplan–Meier method. Extracellular matrix was examined with Masson's trichrome staining. Therapeutic efficacy was evaluated by assessing spontaneous pulmonary metastasis in the B16BL6 melanoma mouse model and growth inhibition of orthotopically implanted hepatoma (n = 4–6). All statistical tests were two-sided. Results: In tumor spheroids and established solid tumors in vivo, transduction with dl-lacZ-RLX, compared with parental virus or vehicle, elicited higher transduction efficiency and viral spread throughout the tumor mass. Infection with Ad-E1B-RLX, compared with parental virus, elicited greater viral persistence and spread, leading to increased survival (e.g., 100%, 95% confidence interval [CI] = 63.1% to 100%, for C33A tumor-bearing mice treated with Ad-E1B-RLX, and 50%, 95% CI = 15.7% to 84.3%, for C33A tumor-bearing mice treated with Ad-E1B). Infection with Ad-E1B-RLX substantially decreased the collagen content of tumor tissue but not of adjacent normal tissue, compared with noninfected tissues. Intratumoral injection of Ad-E1B-RLX inhibited the formation of lung metastases in mice (PBS = 268 mg of metastatic tumor per mouse and Ad-E1B-RLX = 10 mg; difference = 258 mg, 95% CI = 94 to 426; P = .003, Mann–Whitney test). Systemic treatment with Ad-E1B-RLX completely inhibited the growth of Hep1 hepatocellular carcinomas (PBS = 20.2 mg of tumor per mouse and Ad-E1B-RLX = 0 mg; difference = 20.2 mg, 95% CI = 3.7 to 36.7; P = .004, Mann–Whitney test). Conclusion: Extracellular matrix degradation by relaxin expressed by adenoviruses increased viral distribution and tumor penetration, inhibited tumor growth and metastasis, and increased survival of mice.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Li, Y. Liu, S. Tuve, Y. Xun, X. Fan, L. Min, Q. Feng, N. Kiviat, H.-P. Kiem, M. L. Disis, et al. Toward a stem cell gene therapy for breast cancer Blood, May 28, 2009; 113(22): 5423 - 5433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Park, J. Semyonov, W. Yi, C. L. Chang, and S. Y. T. Hsu Regulation of Receptor Signaling by Relaxin A Chain Motifs: DERIVATION OF PAN-SPECIFIC AND LGR7-SPECIFIC HUMAN RELAXIN ANALOGS J. Biol. Chem., November 14, 2008; 283(46): 32099 - 32109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Henshaw, B. Mossop, and F. Yuan Relaxin treatment of solid tumors: effects on electric field-mediated gene delivery Mol. Cancer Ther., August 1, 2008; 7(8): 2566 - 2573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ganesh, M. Gonzalez-Edick, D. Gibbons, M. Van Roey, and K. Jooss Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models Clin. Cancer Res., June 15, 2008; 14(12): 3933 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Winnard Jr., A. P. Pathak, S. Dhara, S. Y. Cho, V. Raman, and M. G. Pomper Molecular Imaging of Metastatic Potential J. Nucl. Med., June 1, 2008; 49(Suppl_2): 96S - 112S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nagano, J. Y. Perentes, R. K. Jain, and Y. Boucher Cancer Cell Death Enhances the Penetration and Efficacy of Oncolytic Herpes Simplex Virus in Tumors Cancer Res., May 15, 2008; 68(10): 3795 - 3802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ganesh, M. Gonzalez Edick, N. Idamakanti, M. Abramova, M. VanRoey, M. Robinson, C.-O. Yun, and K. Jooss Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice Cancer Res., May 1, 2007; 67(9): 4399 - 4407. [Abstract] [Full Text] [PDF]
|
|